Central Health minister J.P. Nadda said that the government is making efforts to lower the prices of drugs and promote use of generic medicines as part of efforts to make them more affordable for the people. National Pharmaceutical Pricing Authority (NPPA) through a notification in July had capped the maximum retail price of 108 non-scheduled single ingredient drug formulations related to treatment for diabetes and cardiovascular diseases.
Out of 108 medicines, only two notifications were withdrawn because they were already covered as scheduled medicines.
A large number of manufacturers have already implemented the price reduction.
Responding to queries on the price of anti-cancer tablet Gilvec, he said, as per the price list in Form V of the DPCO, 2013, the medicine is sold at Rs 8,452.38 for 30 tablets, which is in conformity with the ceiling price notified for this drug formulation.